Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
about
Alternative fuels for cancer cellsIdentification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancerMetabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomasHigh resolution magic angle spinning 1H NMR of childhood brain and nervous system tumoursMolecular characterization and quantification using state of the art solid-state adiabatic TOBSY NMR in burn trauma.A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T.Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS)Characterizing human cancer metabolomics with ex vivo 1H HRMAS MRS.Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsSerum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.Semi-parametric time-domain quantification of HR-MAS data from prostate tissueMerging transcriptomics and metabolomics--advances in breast cancer profiling.Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.Magnetic resonance in the detection of breast cancers of different histological types.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerEvaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue.Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene ExpressionAn HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsyPrognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.A joint analysis of metabolomics and genetics of breast cancer.Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.Early detection of recurrent breast cancer using metabolite profiling.HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.Study of metabonomic profiles of human esophageal carcinoma by use of high-resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis.Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgeryAnalysis of cancer tissues by means of spectroscopic methodsClinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.Metabolic changes in psoriatic skin under topical corticosteroid treatmentMetabolic characterization of triple negative breast cancer.Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy.Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapyIncreased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopyMagic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissuesApplication of metabolomics in thyroid cancer research.Serum metabolomics analysis reveals changes in signaling lipids in breast cancer patients.
P2860
Q26997591-4E7A5B58-1916-4D68-AA90-D6AE7E46E129Q28478197-94825625-088A-49DA-99B2-132B57837573Q33269605-D4822008-4A21-4257-882D-E1109EDDEAF9Q33408011-4B6C4643-1C5F-4C21-AFBC-96E35173CB97Q33514649-BA311C7D-59FA-46EC-BC93-9162A813A48EQ33517556-256485C2-9161-45EA-8E7A-32A6C84E5A0AQ33552272-C726E5E0-12DC-4523-BC9F-A4FDBED4B875Q33631468-31C0BF28-33C4-436A-B066-2C678B8242E1Q33631482-6C4DCE71-E4F8-404A-9052-1357ACF118CAQ33660965-3B6F45E7-7768-441F-8A3C-85EF9F2BAEB4Q33687106-D0936513-B0AA-4E89-BDB2-3FCA84DB595FQ33693035-F9B86696-3B88-4233-814B-BAF75CB69585Q33748176-62EC8434-1B2D-48FF-B300-BA3200C07E54Q33748180-AF93FCC6-9144-4BE8-AD07-000C44EACB6CQ33844930-C37275E5-16A7-4226-A8D1-107754D7AC7BQ33844954-54D6108F-642B-40AD-86CA-FEABF423A8D6Q33873362-25CD0294-5460-45C9-85F7-A9B0BEB1FECAQ33881902-A44B8319-262E-4339-BECA-9A143367608BQ33890692-797F1434-C415-4342-9757-E5223A30B956Q33940135-14AA6FA8-56EB-454A-9D74-E632E09AA830Q34016780-88528AF4-6754-4E81-B044-21A337095CC5Q34041364-1CCEA4E2-4459-4A91-8983-23149A70804CQ34058288-08ABBC06-4E4A-4833-866F-28D7666329E9Q34140986-056B9520-7F64-47B9-B592-9EDA2CC67C22Q34296486-310195AF-A9B4-447E-A32E-F8CF6B4EC3C1Q34346725-536FE30F-88B0-4483-92AB-73E491321D41Q34369288-45986DC5-CF4A-4271-BED7-50BD5B77FBB3Q34525558-BCD6BC37-628E-4CF4-AC93-C8975300736CQ34605817-4A295D57-643A-42E8-A6BD-D6A913E2CD40Q34684585-A94AF1E2-3011-4FF5-B32B-D28BF05F5A42Q34780175-CAB81653-8369-4F07-8F15-2787D7ED3932Q34788629-4C0C2DCB-CDD6-4E7A-9025-47F9FCF2E48AQ34941232-54016433-EEC1-4DED-B387-6671BF795117Q34967995-D3F746FA-7BA3-4DB0-98EC-4DC1401EA13CQ34971676-9E7AD407-8D4E-4A72-AE76-766C10FCA81AQ35075617-2770970D-247D-4472-BD25-28532CCDCD01Q35497704-53F70634-4725-467A-8C08-5B6752FEAE68Q35529046-FF4C99C2-3D80-46EA-B70F-2DB90681332EQ35564078-8BE81EAF-E33D-43E4-9D1E-EA8AB59B78F1Q35693105-B5638EB5-6357-4ED1-8BE5-F9B4E27321AB
P2860
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@en
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@nl
type
label
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@en
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@nl
prefLabel
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@en
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@nl
P50
P356
P1433
P1476
Comparison of HR MAS MR spectr ...... ssue with clinical parameters.
@en
P2093
Hans E Fjosne
P2860
P356
10.1002/NBM.992
P577
2006-02-01T00:00:00Z